Statistics indicate investors love exchange-traded products. U.S.-listed ETFs and ETNs topped $1.3 trillion in assets under management in December 2012 and the inflows have continued this year.
In February, global exchange-traded products attracted $11.4 billion in assets, according to ETFGI.
Through the end of February, global ETFs and ETPs raked in $49.1 billion in new assets with equity-based products accounting for the bulk of inflows with $45.1 billion, ETFGI said. That is good news for the ETF industry, but there is a cause for concern: So-called investors are showing some reluctance in embracing ETFs.
"When asked about their investment preferences in the next 12 months, conservative and moderate investors said they are more likely to opt for mutual funds (86 percent combined) than more aggressive investors (54 percent)," according to Illinois-based Huber Financial, a financial advisory firm.
The firm cited a recent survey conducted by Spectrem's Millionaire Corner that indicates investors with moderate or aggressive risk-tolerance profiles are far more likely to embrace ETFs than their conservative counterparts.
Arguably, this scenario indicates conservative investors are not being properly educated about how they can also benefit from ETFs. Perhaps financial advisors that count risk-adverse investors among their clientele should highlight examples such as the following.
Consumer Staples Select Sector SPDR (NYSE:XLP) It can be argued that the Consumer Staples Select Sector SPDR, the largest staples sector ETF, is among the ultimate options for conservative investors. With an expense ratio of just 0.18 percent, XLP has annualized volatility just 10 percent and a beta of 0.63 against the S&P 500, according to State Street data.
By comparison, the Fidelity Select Consumer Staples Portfolios (FDFAX) charges a whopping 0.83 percent per year, a minimum investment of $2,500 and a redemption fee of 0.75 percent, according to the fund's web site. All of that for a five-year return of nine percent.
XLP has no redemption fee, no minimum investment and offers intraday liquidity. Over the past five years, XLP has offered better than quadruple the returns of FDFAX.
Vanguard Health Care ETF (NYSE:VHT) The health care sector is another favorite stopping point for conservative, cost-conscious investors and Vanguard certainly obliges them with VHT. VHT's paltry expense ratio of 0.14 percent is the lowest among health care sector ETFs.
Said another way, the expense ratio on the Fidelity Select Health Care Portfolio (FSPHX) is more than 5.7 times the fees charged by VHT. And FSPHX charges the same pesky 0.75 percent redemption fee FDFAX does and has the same absurd $2,500 minimum investment requirement.
For all those fees, investors get a mutual fund that has returned just 10 percent over the past five years with a turnover rate of 105 percent, according to Fidelity. On the other hand, the passively managed VHT has offered five times those returns over the past five years.
iShares High Dividend Equity Fund (NYSE:HDV) The iShares High Dividend Equity Fund is one of many U.S.-focused dividend ETFs that compete against the Income Fund of America (AMECX) issued by American Funds. Owning that mutual fund's "A" shares cost $632 per $10,000 invested over one year, according to the fund's prospectus.
Maybe some advisors can look past that because the Income Fund of America is up 11.5 percent in the past year. Maybe the advisors that feel that way ought to look for a new line of work because HDV is up almost 13.2 percent in the past year with an expense ratio of 0.4 percent.
What is even more damning about this comparison is that HDV, a fine ETF to be sure, is pricier than many of its closest ETF rivals. For example, investors can nab a WisdomTree or Vanguard dividend ETF for less than 40 basis points. That is not a criticism of HDV. Imagine if more investors knew they could use ETFs to get comparable or superior returns to what the Income Fund of America offers at a fraction of the cost. That would probably keep some mutual fund folks awake at night.
For more on ETFs, click here.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.